Submit a Review & Earn an Amazon Gift Card
You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!
Submit ReviewRisdiplam is a selective survival of motor neuron-2 (SMN2) pre-mRNA splicing modifier. It potently enhances SMN2 splicing in vitro (EC1.5X = 4 nM) and increases SMN protein in both brain (up to 100%) and muscle tissues (up to 49%) of transgenic mouse models of spinal muscular atrophy (SMA). Risdiplam dose-dependently increases the number of vesicular glutamate transporter 1 (vGlut1) proprioceptive inputs on motor neurons, the number of L3 to L5 motor neurons, the percentage of fully innervated neuromuscular junctions, and muscle size in the extensor digitorum longus muscles in SMN Δ7 mice.
分子量 | 401.47 |
公式 | C22H23N7O |
储存 | Store at -20°C |
纯度 | ≥98% (HPLC) |
CAS Number | 1825352-65-5 |
PubChem ID | 118513932 |
InChI Key | ASKZRYGFUPSJPN-UHFFFAOYSA-N |
Smiles | O=C1C=C(N=C2C=CC(=CN12)N3CCNC4(C3)CC4)C5=NN6C=C(N=C6C(=C5)C)C |
上方提供的技术数据仅供参考。批次相关数据请参见分析证书。
Tocris products are intended for laboratory research use only, unless stated otherwise.
溶剂 | 最高浓度 mg/mL | 最高浓度 mM | |
---|---|---|---|
溶解性 | |||
1eq. HCl | 40.15 | 100 温和加热 |
以下数据基于产品分子量 401.47。 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
浓度/溶剂体积/质量 | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 2.49 mL | 12.45 mL | 24.91 mL |
5 mM | 0.5 mL | 2.49 mL | 4.98 mL |
10 mM | 0.25 mL | 1.25 mL | 2.49 mL |
50 mM | 0.05 mL | 0.25 mL | 0.5 mL |
参考文献是支持产品生物活性的出版物。
Ratni et al (2018) Discovery of Risdiplam, a selective survival of motor neuron-2 (SMN2) gene splicing modifier. for the treatment of spinal muscular atrophy (SMA). J.Med.Chem. 61 6501 PMID: 30044619
Markati et al (2022) Risdiplam: an investigational survival motor neuron 2 (SMN2) splicing modifier for spinal muscular atrophy (SMA). Expert Opin.Investig.Drugs 31 451 PMID: 35316106
Zhao et al (2021) SMN protein is required throughout life to prevent spinal muscular atrophy disease progression. Hum.Mol.Genet. 31 82 PMID: 34368854
Poirier et al (2018) Risdiplam distributes and increases SMN protein in both the central nervous system and peripheral organs. Pharmacol.Res.Perspect 6 e00447 PMID: 30519476
Martin et al (2021) Screening strategies for identifying RNA- and ribonucleoprotein-targeted compounds. Trends Pharmacol.Sci. 42 758 PMID: 34215444
Paik et al (2022) Risdiplam: A Review in Spinal Muscular Atrophy. CNS Drugs 36 401 PMID: 35284988
If you know of a relevant reference for Risdiplam, please let us know.
关键词: Risdiplam, Risdiplam supplier, Risdiplam, RO7034067, RG7916, survival, of, motor, neuron-2, SMN2, pre-mRNA, splicing, modifier, modulator, spinal, muscular, atrophy, SMA, DNA,, RNA, and, Protein, Synthesis, 7916, Tocris Bioscience
引用文献是使用了 Tocris 产品的出版物。
目前没有 Risdiplam 的引用文献。 您是否知道使用了 Tocris Risdiplam 的优秀论文? 请告知我们.
目前没有该产品的评论。 Be the first to review Risdiplam and earn rewards!
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!
*请注意,Tocris 仅会向正规科研企业/机构地址发送文献。
This product guide provides a review of the cell cycle and DNA damage research area and lists over 150 products, including research tools for:
This product guide provides a background to Huntington's disease research and lists around 100 products for the study of: